Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - IPG PHOTONICS CORPFinancial_Report.xls
EX-10.1 - EXHIBIT 10.1 - IPG PHOTONICS CORPexhibit101amendmenttothelo.htm
EX-32 - EXHIBIT 32 - IPG PHOTONICS CORPex-32q12015.htm
EX-31.2 - EXHIBIT 31.2 - IPG PHOTONICS CORPex-312q12015.htm
EX-31.1 - EXHIBIT 31.1 - IPG PHOTONICS CORPex-311q12015.htm
EX-10.2 - EXHIBIT 10.2 - IPG PHOTONICS CORPexhibit102revolvingcredita.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________
FORM 10-Q
__________________________________________
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-33155 
IPG PHOTONICS CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
04-3444218
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification Number)
 
 
50 Old Webster Road,
Oxford, Massachusetts
01540
(Address of principal executive offices)
(Zip code)
(508) 373-1100
(Registrant’s telephone number, including area code)
__________________________________________ 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  ý    NO  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  ý    NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
 
Large Accelerated Filer
ý
  
Accelerated Filer
¨
Non-Accelerated Filer
¨
  
Smaller Reporting Company
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES  ¨    NO  ý
As of May 4, 2015, there were 52,628,565 shares of the registrant's common stock issued and outstanding.



TABLE OF CONTENTS
 
 
Page
EX-10.1 AMENDED AND RESTATED LOAN AGREEMENT WITH BANK OF AMERICA, N.A.
 
EX-10.2 REVOLVING CREDIT NOTE WITH BANK OF AMERICA, N.A.
 
EX-31.1 CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a)
 
EX-31.2 CERTIFICATION OF CFO PURSUANT TO RULE 13a-14(a)
 
EX-32 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 1350
 
EX-101.INS XBRL INSTANCE DOCUMENT
 
EX-101.SCH XBRL TAXONOMY EXTENSION SCHEMA
 
EX-101.CAL XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
 
EX-101.LAB XBRL TAXONOMY EXTENSION LABEL LINKBASE
 
EX-101.PRE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
 
EX-101.DEF XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
 




PART I-FINANCIAL INFORMATION
ITEM 1. UNAUDITED INTERIM FINANCIAL STATEMENTS
IPG PHOTONICS CORPORATION
CONSOLIDATED BALANCE SHEETS
 
March 31,
 
December 31,
 
2015
 
2014
 
(In thousands, except share
and per share data)
ASSETS
CURRENT ASSETS:
 
 
 
Cash and cash equivalents
$
541,474

 
$
522,150

Accounts receivable, net
149,781

 
143,109

Inventories
174,140

 
171,009

Prepaid income taxes
25,712

 
20,967

Prepaid expenses and other current assets
23,785

 
21,295

Deferred income taxes, net
16,136

 
15,308

Total current assets
931,028

 
893,838

DEFERRED INCOME TAXES, NET
5,868

 
5,438

GOODWILL
519

 
455

INTANGIBLE ASSETS, NET
14,913

 
9,227

PROPERTY, PLANT AND EQUIPMENT, NET
274,145

 
275,082

OTHER ASSETS
22,787

 
26,847

TOTAL
$
1,249,260

 
$
1,210,887

LIABILITIES AND EQUITY
CURRENT LIABILITIES:
 
 
 
Revolving line-of-credit facilities
$
523

 
$
2,631

Current portion of long-term debt
13,000

 
13,333

Accounts payable
15,916

 
17,141

Accrued expenses and other liabilities
62,209

 
64,057

Deferred income taxes, net
5,876

 
3,241

Income taxes payable
25,606

 
21,672

Total current liabilities
123,130

 
122,075

DEFERRED INCOME TAXES AND OTHER LONG-TERM LIABILITIES
26,444

 
22,584

LONG-TERM DEBT, NET OF CURRENT PORTION
19,167

 
19,667

Total liabilities
168,741

 
164,326

COMMITMENTS AND CONTINGENCIES (NOTE 12)

 

IPG PHOTONICS CORPORATION STOCKHOLDERS' EQUITY:
 
 
 
Common stock, $0.0001 par value, 175,000,000 shares authorized; 52,620,428 shares issued and outstanding at March 31, 2015; 52,369,688 shares issued and outstanding at December 31, 2014
5

 
5

Additional paid-in capital
580,926

 
567,617

Retained earnings
648,561

 
591,202

Accumulated other comprehensive loss
(150,539
)
 
(112,263
)
Total IPG Photonics Corporation stockholders' equity
1,078,953

 
1,046,561

NONCONTROLLING INTERESTS
1,566

 

Total equity
1,080,519

 
1,046,561

TOTAL
$
1,249,260

 
$
1,210,887

See notes to consolidated financial statements.

1


IPG PHOTONICS CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
 
 
Three Months Ended March 31,
 
2015
 
2014
 
(in thousands, except per share data)
NET SALES
$
198,960

 
$
170,575

COST OF SALES
91,133

 
81,291

GROSS PROFIT
107,827

 
89,284

OPERATING EXPENSES:
 
 
 
Sales and marketing
7,549

 
7,165

Research and development
14,230

 
12,784

General and administrative
12,778

 
12,916

Gain on foreign exchange
(8,752
)
 
(1,370
)
Total operating expenses
25,805

 
31,495

OPERATING INCOME
82,022

 
57,789

OTHER (EXPENSE) INCOME, Net:
 
 
 
Interest expense, net
(184
)
 
(139
)
Other income, net
85

 
334

Total other (expense) income
(99
)
 
195

INCOME BEFORE PROVISION FOR INCOME TAXES
81,923

 
57,984

PROVISION FOR INCOME TAXES
(24,577
)
 
(17,453
)
NET INCOME
57,346

 
40,531

LESS: NET (LOSS) INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS
(13
)
 

NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION
$
57,359

 
$
40,531

NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE:
 
 
 
Basic
$
1.09

 
$
0.78

Diluted
$
1.08

 
$
0.77

WEIGHTED AVERAGE SHARES OUTSTANDING:
 
 
 
Basic
52,486

 
51,970

Diluted
53,267

 
52,724

See notes to consolidated financial statements.


2


IPG PHOTONICS CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
Three Months Ended March 31,
 
2015
 
2014
 
 
 
 
Net income
$
57,346

 
$
40,531

Other comprehensive income, net of tax:
 
 
 
Translation adjustments
(38,319
)
 
(12,666
)
Unrealized gain on derivatives
43

 
39

Total other comprehensive loss
(38,276
)
 
(12,627
)
Comprehensive income
19,070

 
27,904

Comprehensive (loss) income attributable to noncontrolling interest
(13
)
 

Comprehensive income attributable to IPG Photonics Corporation
$
19,083

 
$
27,904

See notes to consolidated financial statements.


3


IPG PHOTONICS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Three Months Ended March 31,
 
2015
 
2014
 
(In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Net income
$
57,346

 
$
40,531

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
9,743

 
8,102

Deferred income taxes
5,708

 
(2,610
)
Stock-based compensation
4,127

 
3,267

Realized and unrealized gains on cash and cash equivalents and unrealized gains on foreign currency transactions
(5,415
)
 
(1,355
)
Other
50

 
422

Provisions for inventory, warranty & bad debt
8,017

 
5,284

Changes in assets and liabilities that (used) provided cash:
 
 
 
Accounts receivable
(11,885
)
 
(4,373
)
Inventories
(13,898
)
 
(3,856
)
Prepaid expenses and other current assets
(723
)
 
(4,731
)
Accounts payable
(1,231
)
 
516

Accrued expenses and other liabilities
(2,774
)
 
3,934

Income and other taxes payable
7,716

 
(175
)
Tax benefit from exercise of employee stock options
(4,773
)
 
(1,565
)
Net cash provided by operating activities
52,008

 
43,391

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of and deposits on property, plant and equipment
(14,027
)
 
(11,456
)
Proceeds from sales of property, plant and equipment
131

 
119

Acquisition of businesses, net of cash acquired
(4,958
)
 

Other
60

 
32

Net cash used in investing activities
(18,794
)
 
(11,305
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Proceeds from line-of-credit facilities
3,616

 
10,889

Payments on line-of-credit facilities
(5,488
)
 
(11,861
)
Principal payments on long-term borrowings
(833
)
 
(333
)
Exercise of employee stock options and issuances under employee stock purchase plan
4,409

 
611

Tax benefit from exercise of employee stock options
4,773

 
1,565

Net cash provided by financing activities
6,477

 
871

EFFECT OF CHANGES IN EXCHANGE RATES ON CASH AND CASH EQUIVALENTS
(20,367
)
 
(1,124
)
NET INCREASE IN CASH AND CASH EQUIVALENTS
19,324

 
31,833

CASH AND CASH EQUIVALENTS — Beginning of period
522,150

 
448,776

CASH AND CASH EQUIVALENTS — End of period
$
541,474

 
$
480,609

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
 
 
 
Cash paid for interest
$
293

 
$
102

Cash paid for income taxes
$
11,889

 
$
20,893

Non-cash transactions:
 
 
 
Demonstration units transferred from inventory to other assets
$
634

 
$
610

Inventory transferred to machinery and equipment
$
284

 
$
717

Additions to property, plant and equipment included in accounts payable
$
549

 
$
1,541

See notes to consolidated financial statements.

4


IPG PHOTONICS CORPORATION
CONSOLIDATED STATEMENTS OF EQUITY
 
 
Three Months Ended March 31,
 
2015
 
2014
 
(In thousands, except share and per share data)
 
Shares
 
Amount
 
Shares
 
Amount
COMMON STOCK
 
 
 
 
 
 
 
Balance, beginning of year
52,369,688

 
$
5

 
51,930,978

 
$
5

Exercise of stock options
250,740

 

 
89,443

 

Balance, end of period
52,620,428

 
5

 
52,020,421

 
5

ADDITIONAL PAID-IN CAPITAL
 
 
 
 
 
 
 
Balance, beginning of year
 
 
567,617

 
 
 
538,908

Stock-based compensation
 
 
4,127

 
 
 
3,267

Exercise of stock options and related tax benefit from exercise
 
 
9,182

 
 
 
2,176

Balance, end of period
 
 
580,926

 
 
 
544,351

RETAINED EARNINGS
 
 
 
 
 
 
 
Balance, beginning of year
 
 
591,202

 
 
 
390,757

Net income attributable to IPG Photonics Corporation
 
 
57,359

 
 
 
40,531

Balance, end of period
 
 
648,561

 
 
 
431,288

ACCUMULATED OTHER COMPREHENSIVE LOSS
 
 
 
 
 
 
 
Balance, beginning of year
 
 
(112,263
)
 
 
 
(1,701
)
Translation adjustments
 
 
(38,319
)
 
 
 
(12,666
)
Unrealized gain on derivatives, net of tax
 
 
43

 
 
 
39

Balance, end of period
 
 
(150,539
)
 
 
 
(14,328
)
TOTAL IPG PHOTONICS CORPORATION STOCKHOLDERS' EQUITY
 
 
$
1,078,953

 
 
 
$
961,316

NONCONTROLLING INTERESTS
 
 
 
 
 
 
 
Balance, beginning of year
 
 

 
 
 

NCI of acquired company
 
 
1,579

 
 
 

Net (loss) income attributable to NCI
 
 
(13
)
 
 
 

Balance, end of period
 
 
1,566

 
 
 

TOTAL STOCKHOLDERS' EQUITY
 
 
$
1,080,519

 
 
 
$
961,316

See notes to consolidated financial statements.

5


IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared by IPG Photonics Corporation, or "IPG", "we", "our", "its" or the "Company". Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The consolidated financial statements include the Company's accounts and those of its subsidiaries. All intercompany balances have been eliminated in consolidation. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2014.
In the opinion of the Company's management, the unaudited financial information for the interim periods presented reflects all adjustments necessary for a fair presentation of the Company's financial position, results of operations and cash flows. The results reported in these consolidated financial statements are not necessarily indicative of results that may be expected for the entire year.
The Company has evaluated subsequent events through the time of filing this Quarterly Report on Form 10-Q with the SEC.
2. RECENT ACCOUNTING PRONOUNCEMENTS
Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require
adoption until a future date are not expected to have a material impact on the Company's financial statements upon adoption.
3. INVENTORIES
Inventories consist of the following:
 
March 31,
 
December 31,
 
2015
 
2014
Components and raw materials
$
54,004

 
$
54,925

Work-in-process
52,016

 
58,603

Finished goods
68,120

 
57,481

Total
$
174,140

 
$
171,009

The Company recorded inventory provisions totaling $3,326 and $2,380 for the three months ended March 31, 2015 and 2014, respectively. These provisions relate to the recoverability of the value of inventories due to technological changes and excess quantities. These provisions are reported as a reduction to components and raw materials and finished goods.
4. ACCRUED EXPENSES AND OTHER LIABLILITES
Accrued expenses and other liabilities consist of the following:
 
March 31,
 
December 31,
 
2015
 
2014
Accrued compensation
$
22,421

 
$
31,673

Customer deposits and deferred revenue
22,703

 
16,605

Current portion of accrued warranty
9,991

 
9,489

Other
7,094

 
6,290

Total
$
62,209

 
$
64,057


6

IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(In thousands, except share and per share data)


5. FINANCING ARRANGEMENTS
The Company's borrowings under existing financing arrangements consist of the following:
 
 
March 31,
 
December 31,
 
2015
 
2014
Revolving line-of-credit facilities:
 
 
 
European overdraft facilities
$
523

 
$
828

Euro line of credit

 
1,803

Total
$
523

 
$
2,631

Term debt:
 
 
 
U.S. long-term note
$
11,000

 
$
11,333

Collateralized long-term note
21,167

 
21,667

Less: current portion
(13,000
)
 
(13,333
)
Total long-term debt
$
19,167

 
$
19,667

The U.S. and Euro lines of credit are available to certain foreign subsidiaries and allow for borrowings in the local currencies of those subsidiaries. At March 31, 2015 and December 31, 2014, there were no amounts drawn on the U.S. line of credit, however there were $32 and $87, respectively, of guarantees issued against the line which reduces total availability. At March 31, 2015, there were no amounts drawn on the Euro line of credit, however, there were $8,207 and $4,309 of guarantees issued against the line as of March 31, 2015 and December 31, 2014, respectively, which reduces total availability. On April 30, 2015, the Company increased its line of credit with Bank of America to $50,000 and extended the maturity to April 2020. The Company has allocated a portion of the available credit under the facility to its foreign subsidiaries for borrowings in their respective local currencies.
As of March 31, 2015, the remaining balance of the U.S. long-term note outstanding is considered current because the note matures in June 2015.
6. NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE
The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per share:
 
Three Months Ended March 31,
 
2015
 
2014
Net income attributable to IPG Photonics Corporation
$
57,359

 
$
40,531

Weighted average shares
52,486

 
51,970

Dilutive effect of common stock equivalents
781

 
754

Diluted weighted average common shares
53,267

 
52,724

Basic net income attributable to IPG Photonics Corporation per share
$
1.09

 
$
0.78

Diluted net income attributable to IPG Photonics Corporation per share
$
1.08

 
$
0.77

The computation of diluted weighted average common shares excludes options to purchase 88,000 shares and 70,000 shares for the three months ended March 31, 2015 and 2014, respectively, because the effect would be anti-dilutive.
7. DERIVATIVE FINANCIAL INSTRUMENTS
Derivative instruments The Company's primary market exposures are to interest rates and foreign exchange rates. The Company uses certain derivative financial instruments to help manage these exposures. The Company executes these instruments with financial institutions it judges to be credit-worthy. The Company does not hold or issue derivative financial instruments for trading or speculative purposes.
The Company recognizes all derivative financial instruments as either assets or liabilities at fair value in the consolidated balance sheets. The Company has an interest rate swap that is classified as a cash flow hedge of its variable rate debt. The Company has no derivatives that are not accounted for as a hedging instrument.

7

IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(In thousands, except share and per share data)


Cash flow hedges The Company's cash flow hedge is an interest rate swap under which it pays fixed rates of interest. The fair value amounts in the consolidated balance sheet related to the interest rate swap were:
Notional Amounts1
 
Other Assets
 
Other Current Liabilities2
 
Other Long-Term Liabilities2

March 31,
 
December 31,
 
March 31,
 
December 31,
 
March 31,
 
December 31,
 
March 31,
 
December 31,
2015
 
2014
 
2015
 
2014
 
2015
 
2014
 
2015
 
2014
$
11,000

 
$
11,333

 
$

 
$

 
$
85

 
$
151

 
$

 
$

  (1) Notional amounts represent the gross contract/notional amount of the derivatives outstanding.
  (2) As of March 31, 2015, the remaining balance of the U.S. long-term note outstanding is considered current because the note matures in June 2015.
The derivative gains and losses in the consolidated statements of income related to the Company's interest rate swap contracts were as follows:
 
Three Months Ended March 31,
 
2015
 
2014
Effective portion recognized in other comprehensive loss, pretax:
 
 
 
Interest rate swap
$
133

 
$
138

Effective portion reclassified from other comprehensive loss to interest expense, pretax:
 
 
 
Interest rate swap
$
(67
)
 
$
(76
)
Ineffective portion recognized in income:
 
 
 
Interest rate swap
$

 
$

8. FAIR VALUE MEASUREMENTS
The Company's financial instruments consist of cash equivalents, accounts receivable, accounts payable, drawings on revolving lines of credit, auction rate securities, long-term debt and certain derivative instruments.
The valuation techniques used to measure fair value are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect internal market assumptions. These two types of inputs create the following fair value hierarchy: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
The carrying amounts of cash equivalents, accounts receivable, accounts payable and drawings on revolving lines of credit are considered reasonable estimates of their fair market value, due to the short maturity of these instruments or as a result of the competitive market interest rates, which have been negotiated. If measured at fair value, accounts receivable and accounts payable would be classified as Level 3 and drawings on the revolving lines of credit would be classified as Level 2.

8

IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(In thousands, except share and per share data)


The following table presents information about the Company’s assets and liabilities measured at fair value:
 
 
 
 Fair Value Measurements at March 31, 2015
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
277,652

 
$
277,652

 
$

 
$

Auction rate securities
1,130

 

 

 
1,130

Total assets
$
278,782

 
$
277,652

 
$

 
$
1,130

Liabilities
 
 
 
 
 
 
 
Contingent purchase consideration
$
83

 
$

 
$

 
$
83

Interest rate swaps
85

 

 
85

 

Total liabilities
$
168

 
$

 
$
85

 
$
83

 
 
 
 
 
 
 
 
 
 
 
 Fair Value Measurements at December 31, 2014
 
 
 
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Cash equivalents
$
266,011

 
$
266,011

 
$

 
$

Auction rate securities
1,128

 

 

 
1,128

Total assets
$
267,139

 
$
266,011

 
$

 
$
1,128

Liabilities
 
 
 
 
 
 
 
Contingent purchase consideration
$
98

 
$

 
$

 
$
98

Interest rate swaps
151

 

 
151

 

Total liabilities
$
249

 
$

 
$
151

 
$
98

The fair value of the auction rate securities considered prices observed in inactive secondary markets for the securities held by the Company.
The fair value of accrued contingent consideration incurred was determined using an income approach at the acquisition date and reporting date. That approach is based on significant inputs that are not observable in the market. Key assumptions include assessing the probability of meeting certain milestones required to earn the contingent consideration.
 
Three Months Ended March 31,
 
2015
 
2014
Auction Rate Securities
 
 
 
Balance, beginning of period
$
1,128

 
$
1,120

Change in fair value and accretion
2

 
2

Balance, end of period
$
1,130

 
$
1,122

Contingent Purchase Consideration
 
 
 
Balance, beginning of period
$
98

 
$
375

Change in fair value and currency fluctuations
(15
)
 
(9
)
Balance, end of period
$
83

 
$
366

9. GOODWILL AND INTANGIBLES
The carrying amount of goodwill was $519 and $455 on March 31, 2015 and December 31, 2014, respectively.

9

IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(In thousands, except share and per share data)


Intangible assets, subject to amortization, consisted of the following:
 
March 31, 2015
 
December 31, 2014
 
 
Gross  Carrying
Amount
Accumulated
Amortization
Net  Carrying
Amount
Weighted-
Average  Lives
Gross  Carrying
Amount
Accumulated
Amortization
Net  Carrying
Amount
Weighted-
Average  Lives
 
 
 
 
 
 
 
 
 
Patents
$
6,641

$
(4,309
)
$
2,332

6 Years
$
6,641

$
(4,221
)
$
2,420

6 Years
Customer relationships
3,357

(3,097
)
260

5 Years
3,660

(3,308
)
352

5 Years
Production know-how
6,664

(2,742
)
3,922

8 Years
6,844

(2,630
)
4,214

8 Years
Technology, trademark and tradename
9,587

(1,188
)
8,399

8 Years
3,315

(1,074
)
2,241

8 Years
 
$
26,249

$
(11,336
)
$
14,913

 
$
20,460

$
(11,233
)
$
9,227

 
During the first quarter of 2015, the Company purchased a 76% ownership interest in RukhTekh LLC ("RuchTech"). RuchTech's fair value at the time was $6,579. The Company paid $5,000, which represents the fair value of its ownership interest on March 15, 2015. In connection with this purchase, the Company has included $64 of Goodwill related to expected synergies for the Company's expansion of product offerings with multi-dimension high-power systems platform for large scale cutting, welding and cladding applications and $6,298 of Purchased Technology intangibles as of March 31, 2015.
The purchase price allocation included in the Company's financial statements are not complete and represent the
preliminary fair value estimates as of March 31, 2015 and are subject to subsequent adjustment as the Company obtains
additional information during the measurement period and finalizes its fair value estimates. Any subsequent adjustments to
these fair value estimates occurring during the measurement period will result in an adjustment to goodwill or income, as
applicable.
Amortization expense for the three months ended March 31, 2015 and 2014 was $512 and $543, respectively. The estimated future amortization expense for intangibles for the remainder of 2015 and subsequent years is as follows:
2015
 
2016
 
2017
 
2018
 
2019
 
Thereafter
 
Total
$1,939
 
$2,568
 
$2,568
 
$2,503
 
$1,914
 
$3,421
 
$14,913
10. PRODUCT WARRANTIES
The Company typically provides one to three-year parts and service warranties on lasers and amplifiers. Most of the Company's sales offices provide support to customers in their respective geographic areas. Warranty reserves have generally been sufficient to cover product warranty repair and replacement costs. The following table summarizes product warranty activity recorded during the three months ended March 31, 2015 and 2014.
 
 
2015
 
2014
Balance at January 1
$
19,272

 
$
14,997

Provision for warranty accrual
4,549

 
2,695

Warranty claims
(2,588
)
 
(1,932
)
Foreign currency translation
(1,437
)
 
(107
)
 Balance at March 31
$
19,796

 
$
15,653

Accrued warranty reported in the accompanying consolidated financial statements as of March 31, 2015 and December 31, 2014 consisted of $9,991 and $9,489 in accrued expenses and other liabilities and $9,805 and $9,783 in other long-term liabilities, respectively.
11. INCOME TAXES
A reconciliation of the total amounts of unrecognized tax benefits is as follows:

10

IPG PHOTONICS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
(In thousands, except share and per share data)


 
2015
 
2014
Balance at January 1
$
6,494

 
$
6,501

Reductions of prior period positions

 

Additions for tax positions in prior period

 

(Reductions) additions for tax positions in current period

 

 Balance at March 31
$
6,494

 
$
6,501

Substantially all of the liability for uncertain tax benefits related to various federal, state and foreign income tax matters, would benefit the Company's effective tax rate, if recognized.
12. COMMITMENTS AND CONTINGENCIES
From time to time, the Company may be involved in disputes and legal proceedings in the ordinary course of its business.
These proceedings may include allegations of infringement of intellectual property, commercial disputes and employment
matters. As of March 31, 2015 and through the filing date of these Financial Statements, the Company has no legal proceedings ongoing that management estimates could have a material effect on the Company's Consolidated Financial Statements.



11


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management's current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See "Cautionary Statement Regarding Forward-Looking Statements."
Overview
We are the leading developer and manufacturer of a broad line of high-performance fiber lasers, fiber amplifiers and diode lasers that are used for diverse applications, primarily in materials processing. We sell our products globally to original equipment manufacturers ("OEMs"), system integrators and end users. We market our products internationally primarily through our direct sales force.
We are vertically integrated such that we design and manufacture most of our key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and amplifiers. We also manufacture certain complementary products used with our lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads and chillers. In addition, we offer laser-based systems for certain markets and applications.
Factors and Trends That Affect Our Operations and Financial Results
In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.
Net sales. We derive net sales primarily from the sale of fiber lasers and amplifiers. We also sell diode lasers, communications systems, laser systems and complementary products. We sell our products through our direct sales organization and our network of distributors and sales representatives, as well as system integrators. We sell our products to OEMs that supply materials processing laser systems, communications systems and medical laser systems to end users. We also sell our products to end users that build their own systems which incorporate our products or use our products as an energy or light source. Our scientists and engineers work closely with OEMs, systems integrators and end users to analyze their system requirements and match appropriate fiber laser or amplifier specifications. Our sales cycle varies substantially, ranging from a period of a few weeks to as long as one year or more, but is typically several months.
Sales of our products generally are recognized upon shipment, provided that no obligations remain and collection of the receivable is reasonably assured. Our sales typically are made on a purchase order basis rather than through long-term purchase commitments.
We develop our products to standard specifications and use a common set of components within our product architectures. Our major products are based upon a common technology platform. We continually enhance these and other products by improving their components and developing new components and new product designs.
The average selling prices of our products generally decrease as the products mature. These decreases result from factors such as decreased manufacturing costs and increases in unit volumes, increased competition, the introduction of new products and market share considerations. In the past, we have lowered our selling prices in order to penetrate new markets and applications. Furthermore, we may negotiate discounted selling prices from time to time with certain customers that purchase multiple units.
Gross margin. Our total gross margin in any period can be significantly affected by total net sales in any period, by product mix, that is, the percentage of our revenue in the period that is attributable to higher or lower-power products and the mix of sales between laser and amplifier sources and complete systems, by sales mix between OEM customers who purchase devices from us in high unit volumes and other customers, by mix of sales in different geographies and by other factors, some of which are not under our control.
Our product mix affects our margins because the selling price per watt is generally higher for mid-power devices and certain specialty products than for high-power devices and certain pulsed lasers sold in large volumes. The overall cost of high-power lasers may be partially offset by improved absorption of fixed overhead costs associated with sales of larger volumes of higher-power products because they use a greater number of optical components and drive economies of scale in manufacturing. Also, the profit margins on systems can be lower than margins for our laser and amplifier sources, depending on the configuration, volume and competitive forces, among other factors.

12


The mix of sales between OEM customers and other customers can affect gross margin because we provide sales price discounts on products based on the number of units ordered. As the number of OEM customers increases and the number of units ordered increases, the average sales price per unit will be reduced. We expect that the impact of reduced sales price per unit will be offset by the manufacturing efficiency provided by high unit volume orders, but the timing and extent of achieving these efficiencies may not always match the mix of sales in any given time period or be realized at all.
We also regularly review our inventory for items that are slow-moving, have been rendered obsolete or determined to be excess. Any write-off of such slow-moving, obsolete or excess inventory affects our gross margins. For example, we recorded provisions for inventory totaling $3.3 million and $2.4 million for the three months ended March 31, 2015 and 2014, respectively and $11.3 million, $15.1 million and $8.2 million for the years ended December 31, 2014, 2013 and 2012, respectively.
Sales and marketing expense. We expect to continue to expand our worldwide direct sales organization, build and expand applications centers, hire additional personnel involved in marketing in our existing and new geographic locations, increase the number of units for demonstration purposes and otherwise increase expenditures on sales and marketing activities in order to support the growth in our net sales. As such, we expect that our sales and marketing expenses will increase in the aggregate.
Research and development expense. We plan to continue to invest in research and development to improve our existing components and products and develop new components, products and systems. The amount of research and development expense we incur may vary from period to period. In general, if net sales continue to increase we expect research and development expense to increase in the aggregate.
General and administrative expense. We expect our general and administrative expenses to increase as we continue to invest in systems and resources in management, finance, legal, information technology, human resources and administration to support our worldwide operations. Legal expenses vary from quarter to quarter based primarily upon the level of litigation, transaction and compliance activities.
Major customers. While we have historically depended on a few customers for a large percentage of our annual net sales, the composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales was 27% for the three months ended March 31, 2015 and 23%, 21% and 16% for the full years 2014, 2013 and 2012, respectively. Our largest customer accounted for 12% of our net sales for the three months ended March 31, 2015. We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our significant customers will continue to change. If any of our significant customers substantially reduced their purchases from us, our results would be adversely affected.
Results of Operations for the three months ended March 31, 2015 compared to the three months ended March 31, 2014
Net sales. Net sales increased by $28.4 million, or 16.6%, to $199.0 million for the three months ended March 31, 2015 from $170.6 million for the three months ended March 31, 2014.
 
Three Months Ended March 31,
 
 
 
 
 
2015
 
2014
 
Change
 
 
 
% of Total
 
 
 
% of Total
 
 
 
 
Materials processing
$
192,003

 
96.5
%
 
$
162,724

 
95.4
%
 
$
29,279

 
18.0
 %
Other applications
6,957

 
3.5
%
 
7,851

 
4.6
%
 
(894
)
 
(11.4
)%
Total
$
198,960

 
100.0
%
 
$
170,575

 
100.0
%
 
$
28,385

 
16.6
 %
Sales for materials processing applications increased primarily due to higher sales of high-power, medium-power, QCW lasers, and service, parts and accessories. High-power laser sales increased due to increased demand for cutting, welding and surface structuring applications. Medium-power laser sales increased due to increased demand for laser sintering/3D manufacturing and thin material welding applications. QCW laser sales increased primarily due to welding applications. A relatively new product, optical processing heads, contributed to the increase in service, parts and accessories sales. We continue to see increased acceptance of the advantages of fiber laser technology. A growing number of OEM customers have developed cutting systems that use our high-power lasers and sales of these systems are gaining sales from gas laser systems. Medium-power lasers are increasingly being used for fine material processing such as cutting and welding metals in the consumer electronics industry as well as in 3D printing. We also increased sales of QCW lasers used for cutting and welding thin sheet metal as demand increased for these devices from OEM customers because they are displacing lamp pumped YAG lasers. The decrease in other applications sales relates primarily to decreases in sales of lasers used in advanced applications offset by an increase in sales of lasers used for medical and telecommunication applications.    

13


Cost of sales and gross margin. Cost of sales increased by $9.8 million, or 12.1%, to $91.1 million for the three months ended March 31, 2015 from $81.3 million for the three months ended March 31, 2014. Our gross margin increased to 54.2% for the three months ended March 31, 2015 from 52.3% for the three months ended March 31, 2014. Gross margin increased due to product mix including increased high-power, medium-power and QCW sales partially offset by increased unit sales of low-power, low-cost pulsed lasers, the benefit of lower manufacturing costs due to the depreciation of the Euro and Russian Ruble exchange rates, a decrease in component cost greater than the decrease in average selling prices and increased absorption of our manufacturing overhead partially offset by increased provisions for excess and obsolete inventory and provisions for warranty reserves due to increased sales. Expenses related to provisions for excess or obsolete inventory and other valuation adjustments increased by $0.9 million to $3.3 million, or 1.7% as a percentage of net sales.
Sales and marketing expense. Sales and marketing expense increased by $0.4 million, or 5.4%, to $7.5 million for the three months ended March 31, 2015 from $7.2 million for the three months ended March 31, 2014, primarily as a result of increases in personnel, trade show and depreciation costs. As a percentage of sales, sales and marketing expense decreased to 3.8% for the three months ended March 31, 2015 from 4.2% for the three months ended March 31, 2014.
Research and development expense. Research and development expense increased by $1.4 million, or 11.3%, to $14.2 million for the three months ended March 31, 2015, compared to $12.8 million for the three months ended March 31, 2014, primarily as a result of an increase in personnel and consultant costs, and materials used for research and development. These increases were partially offset by decreased expenses related to outside research and development contracts. Research and development continues to focus on developing new products at different wavelengths including UV, green and mid-infrared lasers as well as developing end user systems, new pulsed laser products including high power pulsed products and ultra-fast pulsed products, improving the electrical efficiency of high power products, enhancing the performance of our internally manufactured components, refining production processes to improve manufacturing yields, developing new accessories and achieving higher output powers. As a percentage of sales, research and development expense decreased to 7.2% for the three months ended March 31, 2015 from 7.5% for the three months ended March 31, 2014.
General and administrative expense. General and administrative expense slightly decreased by $0.1 million, or 1.1%, to $12.8 million for the three months ended March 31, 2015 from $12.9 million for the three months ended March 31, 2014. This was primarily due to lower provisions for, and an increase in recoveries for, bad debt as well as a smaller loss on the disposal of fixed assets that were partially offset by an increase in salaries and benefits, stock based compensation and depreciation. As a percentage of sales, general and administrative expense decreased to 6.4% for the three months ended March 31, 2015 from 7.6% for the three months ended March 31, 2014.
Effect of exchange rates on net sales, gross profit and operating expenses. We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.73, Russian Ruble 35 and Japanese Yen 103, respectively, we would have expected net sales to be $21.6 million higher, gross profit to be $10.9 million higher and total operating expenses would have been $4.1 million higher.
Gain on foreign exchange. We incurred a foreign exchange gain of $8.8 million for the three months ended March 31, 2015 as compared to $1.4 million gain for the three months ended March 31, 2014. The change is primarily attributable to the appreciation of the U.S. Dollar compared to the Euro and Russian Ruble.
Interest expense, net. Interest expense, net remained relatively flat for the three months ended March 31, 2015 and 2014.
Other (expense) income, net. Other (expense) income, remained relatively flat for the three months ended March 31, 2015 and 2014.
Provision for income taxes. Provision for income taxes was $24.6 million for the three months ended March 31, 2015 compared to $17.5 million for the three months ended March 31, 2014. The effective tax rates were 30.0% and 30.1% for the three months ended March 31, 2015 and 2014, respectively. The decrease in effective rate was due primarily to the mix of income earned in various tax jurisdictions.
Net income attributable to IPG Photonics Corporation. Net income attributable to IPG Photonics Corporation increased by $16.8 million to $57.4 million for the three months ended March 31, 2015 compared to $40.5 million for the three months ended March 31, 2014. Net income attributable to IPG Photonics Corporation as a percentage of our net sales increased by 5.0 percentage points to 28.8% for the three months ended March 31, 2015 from 23.8% for the three months ended March 31, 2014 due to the factors described above.
Liquidity and Capital Resources

14


Our principal sources of liquidity as of March 31, 2015 consisted of cash and cash equivalents of $541.5 million, unused credit lines and overdraft facilities of $61.0 million and other working capital (excluding cash and cash equivalents) of $266.4 million. This compares to cash and cash equivalents of $522.2 million, unused credit lines and overdraft facilities of $66.9 million and other working capital (excluding cash and cash equivalents) of $249.6 million as of December 31, 2014. The increase in cash and cash equivalents of $19.3 million from December 31, 2014 relates primarily to the following:
Cash provided by operating activities in the three months ended March 31, 2015 of $52.0 million.
Cash provided by financing activities of $6.5 million from the exercise of stock options and their related tax benefit partially offset by payments on long-term borrowings and net payments of line-of-credit facilities.
Cash used by investing activities of $18.8 million which mostly relate to capital expenditures and the purchase of a 76% interest in a high-power laser systems technology company.
Our long-term debt consists of the remaining balance of a $11.0 million unsecured variable-rate note. The note matures in June 2015, at which time the outstanding debt balance will be $10.7 million. The variable interest rate was fixed at a rate of 2.57% per annum by means of an interest rate swap instrument. Long-term debt also consists of a $21.2 million secured note. The note is secured by our corporate aircraft. Of this amount, $2.0 million is the current portion. The interest rate is fixed at 2.81% per annum and the note matures in October 2019, at which time the outstanding debt balance would be $12.0 million.
We believe that our existing cash and marketable securities, our cash flows from operations and our existing lines of credit provides us with the financial flexibility to meet our liquidity and capital needs, as well as to complete certain acquisitions of complementary businesses and technologies. Our future long-term capital requirements will depend on many factors including our level of sales, the impact of economic environment on our sales levels, the timing and extent of spending to support development efforts, the expansion of the global sales and marketing activities, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products.
The following table details our line-of-credit facilities as of March 31, 2015: 
 
 
 
 
 
 
 
 
 
Description
 
Available Principal
 
Interest Rate
 
Maturity
 
Security
U.S. Revolving Line of Credit (1)
 
Up to $35.0 million
 
LIBOR plus 1.125% to 1.625%, depending on our performance
 
June 2015
 
Unsecured
Euro Credit Facilities (Germany) (2)
 
Euro 30.0 million ($32.5 million)
 
Euribor + 1.00% or EONIA 1.25%
 
July 2017
 
Unsecured, guaranteed by parent company and Germany subsidiary
Euro Overdraft Facilities (3)
 
Euro 2.0 million
($2.2 million)
 
1.0%-6.5%
 
October 2015
 
Common pool of assets of Italian subsidiary
(1)
$14.1 million of this revolving credit facility is available to our foreign subsidiaries in their respective local currencies, including India, China, Japan and South Korea. At March 31, 2015, there were no drawings, however, there were $32 thousand of guarantees issued against the line which reduces the total availability.
(2)
$17.4 million is available to our Russian subsidiary, $8.7 million is available to our German subsidiary, $3.2 million of this credit facility is available to our Chinese subsidiary and $3.2 million is available to our Italian subsidiary. At March 31, 2015, there were no amounts drawn on this line, however, there were $8.2 million of guarantees issued against the line which reduces the total availability.
(3)
At March 31, 2015, $0.5 million of the $2.2 million was drawn upon with an interest rate of 1.0%.
Our largest committed credit lines are with Bank of America and Deutsche Bank in the amounts of $35.0 million and $32.5 million, respectively, and neither of them is syndicated. On April 30, 2015, we increased our line of credit with Bank of America to $50.0 million and extended the maturity to April 2020. We have allocated a portion of the available credit under the facility to our foreign subsidiaries for borrowings in their respective local currencies.
We are required to meet certain financial covenants associated with our U.S. revolving line of credit and long-term debt facilities. These covenants, tested quarterly, include a debt service coverage ratio and a funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") ratio. The debt service coverage covenant requires that we maintain a trailing twelve month ratio of cash flow to debt service that is greater than 1.5:1. Debt service is defined as required principal and interest payments during the period. Under the amended line of credit with the Bank of America, debt service in the calculation

15


is decreased by our cash held in the U.S.A. in excess of $50 million up to a maximum of $250 million. Cash flow is defined as EBITDA less unfunded capital expenditures. The funded debt to EBITDA covenant requires that the sum of all indebtedness for borrowed money on a consolidated basis be less than two times our trailing twelve months EBITDA and, under the amended line of credit facility, less than three times our trailing twelve months EBITDA . We were in compliance with all such financial covenants as of and for the three months ended March 31, 2015.
Operating activities. Net cash provided by operating activities increased by $8.6 million to $52.0 million for the three months ended March 31, 2015 from $43.4 million for the three months ended March 31, 2014, primarily resulting from:
An increase in cash provided by net income after adding back non-cash charges of $79.6 million in the three months ended March 31, 2015 as compared to $53.6 million in the same period in 2014;
An increase in income and other taxes payable of $7.7 million in the three months ended March 31, 2015 as compared to a decrease of $0.2 million in the same period in 2014;
An increase in prepaid expenses and other current assets of $0.7 million in the three months ended March 31, 2015 as compared to an increase of $4.7 million in the same period in 2014; partially offset by
An increase in inventory of $13.9 million in the three months ended March 31, 2015 as compared to an increase of $3.9 million in the same period in 2014;
An increase in accounts receivable of $11.9 million in the three months ended March 31, 2015 as compared to an increase of $4.4 million in the same period in 2014;
A decrease in accrued expenses and other liabilities of $2.8 million in the three months ended March 31, 2015 as compared to an increase of $3.9 million in the same period in 2014; and
The effect of exchange rates on cash related to the appreciation of the U.S. Dollar compared to the Euro and Russian Ruble of $20.4 million.
Given our vertical integration, rigorous and time-consuming testing procedures for both internally manufactured and externally purchased components and the lead time required to manufacture components used in our finished products, the rate at which we turn inventory has historically been comparatively low when compared to our cost of sales. Also, our historic growth rates required investment in inventories to support future sales and enable us to quote short delivery times to our customers, providing what we believe is a competitive advantage. Furthermore, if there was a disruption to the manufacturing capacity of any of our key technologies, our inventories of components should enable us to continue to build finished products for a reasonable period of time. We believe that we will continue to maintain a relatively high level of inventory compared to our cost of sales. As a result, we expect to have a significant amount of working capital invested in inventory. A reduction in our level of net sales or the rate of growth of our net sales from their current levels would mean that the rate at which we are able to convert our inventory into cash would decrease.
Investing activities. Net cash used in investing activities was $18.8 million and $11.3 million in the three months ended March 31, 2015 and 2014, respectively. The cash used in investing activities in 2015 related to the construction of new buildings in the U.S.A., Germany and Russia, purchases of machinery and equipment and the purchase of a 76% interest in a high-power laser systems technology company. The cash used in investing activities in 2014 related to the construction of new buildings in the U.S.A., Germany and Russia.
We expect to incur between $60 million and $65 million in capital expenditures, excluding acquisitions in 2015, as we continue to upgrade facilities and add capacity worldwide to support our anticipated revenue growth. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period.
Financing activities. Net cash provided by financing activities was $6.5 million and $0.9 million in the three months ended March 31, 2015 and 2014, respectively. The cash provided by financing activities in 2015 was primarily related to the cash provided by the exercise of stock options and the related tax benefits of the exercises partially offset by the payments on our long-term borrowings and net payments of line-of-credit facilities. The cash provided by financing activities in 2014 was primarily related to the cash provided by the exercise of stock options and the related tax benefits of the exercises partially offset by the payments on our long-term debt and line-of-credit facilities.
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any

16


statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.
The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, "Business" and Item 1A, "Risk Factors" of Part I of our Annual Report on Form 10-K for the year ended December 31, 2014. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Recent Accounting Pronouncements
Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require
adoption until a future date are not expected to have a material impact on our financial statements upon adoption.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.
Interest rate risk. Our investments have limited exposure to market risk. To minimize this risk, we maintain a portfolio of cash, cash equivalents and short-term investments, consisting primarily of bank deposits, money market funds and short-term government securities. The interest rates are variable and fluctuate with current market conditions. Because of the short-term nature of these instruments, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operations.
We are also exposed to market risk as a result of increases or decreases in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. Our interest obligations on our long-term debt are fixed by means of an interest rate swap agreement. Although our U.S. revolving line of credit and our Euro credit facility have variable rates, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.
Exchange rates. Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. Dollar, principally the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. Dollar, the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan. Gain on foreign exchange transactions totaled $8.8 million and $1.4 million for the three months ended March 31, 2015 and 2014, respectively. Management attempts to minimize these exposures by partially or fully off-setting foreign currency denominated assets and liabilities at our subsidiaries that operate in different functional currencies. The effectiveness of this strategy can be limited by the volume of underlying transactions at various subsidiaries and by our ability to accelerate or delay inter-company cash settlements. As a result, it is unlikely that we will be able to create a perfect offset of the foreign currency denominated assets and liabilities. Furthermore, if the forecast or trend for a certain currency is expected, in the medium or long term, to be in a certain direction we have, on occasions, chosen not to try to off-set the assets or liabilities. At March 31, 2015, our material foreign currency exposure is net U.S. Dollar denominated assets at subsidiaries where the Euro is the functional currency. The net U.S. Dollar denominated assets are comprised of cash, third party receivables, inter-company receivables and inter-company notes offset by third party and inter-company U.S. Dollar denominated payables. A 5% change in the relative exchange rate of the U.S. Dollar to the Euro as of March 31, 2015 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $3.0 million if the U.S. Dollar appreciated and a $3.0 million foreign exchange loss if the U.S. Dollar depreciated.
Foreign currency derivative instruments can also be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We have no foreign currency derivative instrument hedges as of March 31, 2015. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange rate fluctuations may adversely affect our financial results in the future.

17


ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.
Changes in Internal Controls
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

18


PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are party to various legal proceedings and other disputes incidental to our business. There have been no material developments to those proceedings reported in our Annual Report on Form 10-K for the year ended December 31, 2014.
ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2014, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
Date
 
Total Number of
Shares (or Units)
Purchased
 
 
 
Average Price
Paid per Share
(or Unit)
 
Total Number of
Shares (or Units)
Purchased as Part
of Publicly
Announced Plans
or Programs
 
Maximum Number
(or Approximate
Dollar Value) of
Shares (or Units)
that May Yet Be
Purchased Under
the Plans or
Programs
January 1, 2015 — January 31, 2015
 

 
(1
)
 
$

 
$

 
$

February 1, 2015 — February 28, 2015
 

 
(1
)
 

 

 

March 1, 2015 — March 31, 2015
 
2,945

 
(1
)
 
93.29

 

 

Total
 
2,945

 
 
 
$
93.29

 
$

 
$

 
(1)
In 2012, our Board of Directors approved "withhold to cover" as a tax payment method for vesting of restricted stock awards for certain employees. Pursuant to the "withhold to cover" method, we withheld from such employees the shares noted in the table above to cover tax withholding related to the vesting of their awards. The average prices listed in the above table are averages of the fair market prices at which we valued shares withheld for purposes of calculating the number of shares to be withheld in 2015.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
(a) Exhibits
 

19


Exhibit
No.
 
Description
10.1
 
Amended and restated loan agreement with Bank of America, N.A.

10.2
 
Revolving credit note with Bank of America, N.A.

31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32
 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 1350
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase


20


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
IPG PHOTONICS CORPORATION
 
 
 
 
 Date: May 6, 2015
 
By:
/s/ Valentin P. Gapontsev
 
 
 
Valentin P. Gapontsev
 
 
 
Chairman and Chief Executive Officer
(Principal Executive Officer)
 
 
 
 
 Date: May 6, 2015
 
By:
/s/ Timothy P.V. Mammen
 
 
 
Timothy P.V. Mammen
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)


21